PL369544A1 - Pyridine derivatives as nmda receptor ligands - Google Patents

Pyridine derivatives as nmda receptor ligands

Info

Publication number
PL369544A1
PL369544A1 PL02369544A PL36954402A PL369544A1 PL 369544 A1 PL369544 A1 PL 369544A1 PL 02369544 A PL02369544 A PL 02369544A PL 36954402 A PL36954402 A PL 36954402A PL 369544 A1 PL369544 A1 PL 369544A1
Authority
PL
Poland
Prior art keywords
nmda receptor
receptor ligands
pyridine derivatives
pyridine
derivatives
Prior art date
Application number
PL02369544A
Other languages
English (en)
Polish (pl)
Inventor
Alexander Alanine
Bernd Buettelmann
Neidhart Marie-Paule Heitz
Emmanuel Pinard
René Wyler
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL369544A1 publication Critical patent/PL369544A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL02369544A 2001-11-09 2002-11-02 Pyridine derivatives as nmda receptor ligands PL369544A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01126467 2001-11-09

Publications (1)

Publication Number Publication Date
PL369544A1 true PL369544A1 (en) 2005-05-02

Family

ID=8179179

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02369544A PL369544A1 (en) 2001-11-09 2002-11-02 Pyridine derivatives as nmda receptor ligands

Country Status (16)

Country Link
US (1) US6831087B2 (enExample)
EP (1) EP1448547B1 (enExample)
JP (1) JP4188837B2 (enExample)
KR (1) KR100589995B1 (enExample)
CN (1) CN100516061C (enExample)
AR (1) AR037221A1 (enExample)
AT (1) ATE293619T1 (enExample)
AU (1) AU2002351816B8 (enExample)
BR (1) BR0213977A (enExample)
CA (1) CA2467973C (enExample)
DE (1) DE60203820T2 (enExample)
ES (1) ES2240829T3 (enExample)
MX (1) MXPA04004308A (enExample)
PL (1) PL369544A1 (enExample)
RU (1) RU2303037C2 (enExample)
WO (1) WO2003040128A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007008816A (ja) * 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
RU2320654C1 (ru) * 2006-05-24 2008-03-27 Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО ПГФА Росздрава) 2,2-ДИМЕТИЛ-4-(4,6-ДИМЕТИЛ-2-ПИРИДОН-3-ИЛ)-1,2-ДИГИДРО-БЕНЗО[f]ИЗОХИНОЛИНА ГИДРОХЛОРИД, ПРОЯВЛЯЮЩИЙ ПРЯМОЕ АНТИКОАГУЛЯНТНОЕ ДЕЙСТВИЕ
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) * 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
EP2065381A1 (de) 2007-10-18 2009-06-03 Boehringer Ingelheim Pharma GmbH & Co. KG CGRP Antagonisten
MX2010003849A (es) 2007-10-18 2010-04-27 Boehringer Ingelheim Int Antagonistas de cgrp.
EP2225237A2 (de) * 2007-11-22 2010-09-08 Boehringer Ingelheim International GmbH Organische verbindungen
EP2225223B1 (de) 2007-11-22 2017-01-11 Boehringer Ingelheim International GmbH Organische verbindungen
EP2062889A1 (de) * 2007-11-22 2009-05-27 Boehringer Ingelheim Pharma GmbH & Co. KG Verbindungen
EA014100B1 (ru) * 2008-02-21 2010-08-30 Общество С Ограниченной Ответственностью "Валексфарм" Производные 2,4-диаминопиридина, фармацевтическая композиция, лекарственное средство на их основе для лечения или предупреждения заболеваний и нарушений, вызванных гиперактивацией nmda-рецепторов и/или в качестве стимуляторов когнитивных функций и способ лечения
RU2438672C1 (ru) 2010-04-30 2012-01-10 Общество с ограниченной ответственностью "Клевер Фарм" Агент, проявляющий свойства активатора когнитивных функций (варианты)
WO2025124571A1 (zh) * 2023-12-14 2025-06-19 斯莱普泰(上海)生物医药科技有限公司 Nmda受体拮抗剂及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
AU4500399A (en) * 1998-05-25 1999-12-13 Basf Aktiengesellschaft New heterocyclically substituted amides, their production and their use
US6440995B1 (en) * 1999-10-01 2002-08-27 Hoffman-La Roche Inc. Quinolin-4-yl derivatives
EP1088818B1 (en) 1999-10-01 2004-11-03 F. Hoffmann-La Roche Ag Quinolin-4-yl derivatives
US6339093B1 (en) * 1999-10-08 2002-01-15 Hoffmann-La Roche Inc. Isoquinoline derivatives

Also Published As

Publication number Publication date
US20030119870A1 (en) 2003-06-26
US6831087B2 (en) 2004-12-14
CN100516061C (zh) 2009-07-22
DE60203820D1 (de) 2005-05-25
ES2240829T3 (es) 2005-10-16
RU2004117595A (ru) 2006-01-10
DE60203820T2 (de) 2006-02-23
AR037221A1 (es) 2004-10-27
CA2467973A1 (en) 2003-05-15
AU2002351816B8 (en) 2008-04-03
CN1585762A (zh) 2005-02-23
AU2002351816B2 (en) 2008-03-06
ATE293619T1 (de) 2005-05-15
MXPA04004308A (es) 2004-08-11
BR0213977A (pt) 2004-08-31
EP1448547A1 (en) 2004-08-25
WO2003040128A1 (en) 2003-05-15
EP1448547B1 (en) 2005-04-20
JP2005513004A (ja) 2005-05-12
JP4188837B2 (ja) 2008-12-03
KR20050042252A (ko) 2005-05-06
CA2467973C (en) 2009-09-01
RU2303037C2 (ru) 2007-07-20
KR100589995B1 (ko) 2006-06-19

Similar Documents

Publication Publication Date Title
HUP0400249A3 (en) Pyridine derivatives as 5-ht receptor ligands and uses thereof
IL161439A0 (en) Cannabinoid receptor ligands
IL156829A0 (en) Cannabinoid receptor ligands
IL162242A0 (en) Azaindolylalkylamine derivatives as5-hydroxytryptamine-6 ligands
SI1416935T1 (sl) 4-amino-6-fenil-pirolo(2,3-d)pirimidinski derivati
PL373953A1 (en) 7-amino-benzothiazole derivatives as adenosine receptor ligands
PL365377A1 (en) Amide derivatives as nmda receptor antagonists
IL160181A0 (en) N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
AU2003257172A1 (en) Cannabinoid receptor ligands
IL160701A0 (en) 3-substituted-4-pyrimidone derivatives
IL157059A0 (en) 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
AU2002348503A1 (en) Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors
IL161409A0 (en) Methods for ligand discovery
AU2001242744A1 (en) Diphenylalkylamine derivatives useful as opioid delta receptor ligands
PL369544A1 (en) Pyridine derivatives as nmda receptor ligands
PL369470A1 (en) Benzothiazole derivatives as adenosine receptor ligands
PL362844A1 (en) Substituted benzofuran-2-carboxamides derivatives
IL157031A0 (en) Thyroid receptor ligands
HRP20040672A2 (en) Triazolo-quinolin derivatives useful as adenosine receptor ligands
HRP20050540A2 (en) Imidazoquinoline derivatives as adenosine a3 receptor ligands
HUP0401949A3 (en) 4-imidazolin-2-one derivatives
HUP0303186A3 (en) 4-aminobenzopyran derivatives
HUP0500026A3 (en) N-heteroarylnicotinamide derivatives
AU3167402A (en) Aminotriazolopyridiine derivatives as adenosine receptor ligands
AU2001259051A1 (en) Piperidyindoles as serotonin receptor ligands

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)